iPhone | iPad
Android
Huawei
Judges for the AI awards not only recognise excellence and innovation, but also assess performance and monitor progress in artificial intelligence computing and responses
KT APPDOWNLOAD
AstraZeneca Covid-19 vaccine benefits increase with age: EMA
Brussels - 'Vaxzevria is effective at preventing hospitalisations, ICU admissions and deaths'
The EU's drug watchdog said Friday that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
The European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted several countries to restrict its use to older people.
"It showed that the benefits of vaccination increase with increasing age and infection rates," the Amsterdam-based EMA said in statement.
"The benefits of Vaxzevria outweigh its risks in adults of all age groups; however, very rare cases of blood clots with low blood platelets have occurred following vaccination," it added, using the vaccine's brand name.
The rare clots happened in around one in 100,000 people who received the vaccine, it said.
"Vaxzevria is effective at preventing hospitalisations, intensive care unit (ICU) admissions and deaths due to Covid-19. The most common side effects are usually mild or moderate and get better within a few days."
Despite reports that clot cases were more prevalent among women, the EMA said that "there were insufficient data available from across the EU to provide further context on benefits and risks with regard to sex."
Clots are also being listed as a side effect of the J&J vaccine, which uses the same adenovirus vector technology as AstraZeneca, the EMA said earlier this week.
Brussels asked the EMA earlier this month to carry out further investigations, and the watchdog said its announcement on Friday was to "provide an update on the analysis of data" on AstraZeneca.
The EMA said it was also sharing the latest opinion issued by its human medicines committee "aimed at supporting national decision-making on how to best use the vaccine in their territories."
The EU is now increasingly relying for its rollout on the BioNTech/Pfizer vaccine, which uses rival mRNA tech.
The European Commission is also looking to launch legal action against AstraZeneca for underdelivering Covid-19 vaccine doses to the EU, which hobbled its early rollout.
More news from
A plea moved in court stated that no one is permitted to wear the official state institution outfit
Bayer Leverkusen boss Xabi Alonso had been the favourite to succeed Klopp but has now committed himself to the German club after leading them to a first-ever Bundesliga title
Sheikh Hamdan joined the kids as they browsed through some photos that captured how they used broomsticks and helped their community
The family's furniture, household appliances as well as the books and stationery of the children were destroyed in the April 16 floods
The 22-time Grand Slam champion and his wife Maria Francisca Perello welcomed their first child together in October 2022
In line with this year’s theme BNI UAE’s Expo has renowned speakers who will share experiences igniting breakthrough journeys through networking
The Hyderabad-based franchise achieved the coveted century landmark n just their eighth match of the season
